4.6 Article

Anti-cancer effect of palmatine through inhibition of the PI3K/AKT pathway in canine mammary gland tumor CMT-U27 cells

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Palmatine Attenuates Metastatic Lung Colonization of Triple Negative Breast Cancer Cells

Selase Ativui et al.

Summary: This study demonstrated that palmatine has the potential to improve hypoxemia, ameliorate metastasis-associated lung injury, decrease lung MTA1 expression, and increase p53 expression in the treatment of lung metastasis from triple negative breast cancer.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin

Aneta Grabarska et al.

Summary: The study demonstrated the potential of PLT as a candidate drug for preventing and treating breast cancer by inhibiting the viability and proliferation of breast cancer cells, as well as sensitizing the cells to other drugs. Additionally, PLT showed no impact on the growth of normal human breast epithelial cells.

MOLECULES (2021)

Article Biochemistry & Molecular Biology

Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis

Radha Mukherjee et al.

Summary: The PI3K pathway regulates cell metabolism, proliferation, and migration, and dysregulation of this pathway is common in cancer. Physiologic and oncogenic activation of PI3K signaling both lead to increased expression of the negative regulator PTEN, limiting signal duration and pathway output. However, inhibition of the pathway reduces PTEN levels, contributing to pathway rebound in tumors treated with PI3K inhibitors.

MOLECULAR CELL (2021)

Review Oncology

The present and future of PI3K inhibitors for cancer therapy

Pau Castel et al.

Summary: PI3K signaling pathway is commonly activated in human cancers, leading to the development of PI3K inhibitors as a potential therapy. However, current limitations such as toxicity and resistance mechanisms need to be addressed to improve efficacy. Studies on targeting PI3K in solid tumors have shown progress in developing effective inhibitors but face challenges in clinical limitations.

NATURE CANCER (2021)

Article Urology & Nephrology

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer

Cameron Herberts et al.

EUROPEAN UROLOGY (2020)

Article Oncology

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Olga Martinez-Saez et al.

BREAST CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

Palmatine: A review of its pharmacology, toxicity and pharmacokinetics

Jiaying Long et al.

BIOCHIMIE (2019)

Review Pharmacology & Pharmacy

Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer

Fabio Barra et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)

Article Cell Biology

The cell biology behind the oncogenic PIP3 lipids

Ana C. Carrera et al.

JOURNAL OF CELL SCIENCE (2019)

Article Pharmacology & Pharmacy

Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells

Elahe Naderali et al.

ADVANCED PHARMACEUTICAL BULLETIN (2019)

Review Plant Sciences

Natural Products for the Treatment of Type 2 Diabetes Mellitus

Jose Luis Ros et al.

PLANTA MEDICA (2015)

Article Biochemistry & Molecular Biology

Palmatine Inhibits Growth and Invasion in Prostate Cancer Cell: Potential Role for rpS6/NFκB/FLIP

Heather G. Hambright et al.

MOLECULAR CARCINOGENESIS (2015)

Review Oncology

Regulation of angiogenesis by PI3K signaling networks

Mariona Graupera et al.

EXPERIMENTAL CELL RESEARCH (2013)

Article Chemistry, Multidisciplinary

Quantum second virial coefficient calculation for the 4He dimer on a recent potential

Éderson D'Martin Costa et al.

JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2013)

Article Multidisciplinary Sciences

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer

Mahavir B. Chougule et al.

PLOS ONE (2011)

Article Immunology

Canine neoplasia - Introductory paper

Hans Gamlem et al.

APMIS (2008)

Article Veterinary Sciences

Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs

L. Marconato et al.

VETERINARY AND COMPARATIVE ONCOLOGY (2008)

Article Veterinary Sciences

Mammary tumor recurrence in bitches after regional mastectomy

Nina Stratmann et al.

VETERINARY SURGERY (2008)

Review Genetics & Heredity

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

Jeffrey A. Engelman et al.

NATURE REVIEWS GENETICS (2006)

Article Veterinary Sciences

Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002)

SC Chang et al.

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2005)

Article Biotechnology & Applied Microbiology

Use of isogenic human cancer cells for high-throughput screening and drug discovery

CJ Torrance et al.

NATURE BIOTECHNOLOGY (2001)

Article Veterinary Sciences

Adjuvant post-operative chemotherapy in bitches with mammary cancer

M Karayannopoulou et al.

JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE (2001)